| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9867 | HYNIC-cyclo(RGDfK) dimer trifluoroacetate |
9867.0001: 1 mg per vial 9867.0010: 10 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
Precursor for αvβ3 integrin targeted, 99mTc-labelled RGD-peptides
|
||
| Molar Mass: 1453.6 (net peptide) | ||
| C65H92N22O17S2 | ||
| [500166-11-0] | ||
| Colourless to off-white solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity); HPLC (purity) |
||
|
Chemical Name: Sequence: Hynic-cyclo(-Arg-Gly-Asp-D-Phe-Lys-) dimer |
||
|
Synonymes: CA index name: Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-lysyl), 5,5'-[N-[(6-hydrazino-3-pyridinyl)carbonyl]-L-glutamoyl]bis- |
||
|
Literature: Jia B. et al. 99mTc-Labeled Cyclic RGDfK Dimer: Initial Evaluation for SPECT Imaging of Glioma Integrin ανβ3 Expression. Bioconjugate Chem. 2006, 17, 1069-1076. |
||
| Janssen M.L. et al. Tumor Targeting with Radiolabeled ανβ3 Integrin Binding Peptides in a Nude Mouse Model. Cancer Res. 2002, 62, 6146-6151. | ||
| date of product catalogue issue: 10 May 2017 | ||